Sequential Stevens–Johnson syndrome and photo‐recall phenomenon

Lee, Haur Yueh; Philippidou, M.; Marcus, Robert B.; Walsh, Sylvia; Creamer, Daniel

doi:10.1111/j.1365-2133.2011.10734.x

British Journal of Dermatology

2012

DOI: 10.1111/j.1365-2133.2011.10734.x

|View full text |Cite

Sequential Stevens–Johnson syndrome and photo‐recall phenomenon

Haur Yueh Lee¹,

M. Philippidou²,

Robert B. Marcus

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

2016

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 7 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Erythema multiforme (EM) is a reactive skin eruption characterized by target lesions. It is believed to belong to the same skin disease spectrum as Stevens-Johnson syndrome and toxic epidermal necrolysis, and it has been described as a photoinduced or photodistributed dermatosis (3,4). Photosensitive erythema multiforme (PEM) has been reported in association with drugs, herpes simplex virus infection, and other conditions, including polymorphous light eruption (PLE) and juvenile spring eruption (JSE) (5,6), but in many cases the condition is idiopathic (3).…”

mentioning

confidence: 99%

Photoinduced target‐like drug reaction to naproxen

Barboza-Guadagnini

Bassas-Vila

Aguilera

et al. 2016

Photoderm Photoimm Photomed

View full text Add to dashboard Cite

mentioning

confidence: 99%

Photoinduced target‐like drug reaction to naproxen

Barboza-Guadagnini

Bassas-Vila

Aguilera

et al. 2016

Photoderm Photoimm Photomed

View full text Add to dashboard Cite

Life-threatening dermatologic adverse events in oncology

et al. 2014

View full text Add to dashboard Cite

Background: The incidence of life-threatening toxicities such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are inconsistently reported. The potential association of anticancer agents with SJS or TEN has not been systematically investigated. Methods: We searched the literature (Ovid:1950-June 2013 and PubMed:1948-June 2013) using terms for SJS/TEN and anticancer therapy. Primary case reports, case series, and clinical trials were included. Additionally, MedWatch, Food and Drug Administration Adverse Event Reporting System (FAERS), was searched (1968-August 2012) for SJS/TEN reports associated with anticancer therapies. Proportional reporting ratios (PRR>2, N>3) and empirical Bayes geometric mean (EBGM>2, N>3, lower 95% confidence interval (EBGM0.05 >2) were used as thresholds to constitute a signal of association between SJS/TEN and anticancer drugs. Results: There were 45 SJS and 37 TEN cases associated with 17 and 22 anticancer drugs in the literature, respectively. Among cases in FAERS, significant signals were associated with SJS for bendamustine and with TEN for bendamustine, busulfan, chlorambucil, fludarabine, lomustine, and procarbazine . Conclusion: Several drugs reported in published literature to be associated with SJS/TEN were not found to have significant signals in FAERS. Proactive pharmacovigilance to detect and define safety signals serves to assist oncology practitioners in the recognition of possible, yet uncommon, serious and/or life-threatening skin reactions.

show abstract

Photo‐distributed Stevens–Johnson syndrome associated with oral itraconazole

et al. 2016

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Sequential Stevens–Johnson syndrome and photo‐recall phenomenon

Cited by 3 publications

References 7 publications

Photoinduced target‐like drug reaction to naproxen

Photoinduced target‐like drug reaction to naproxen

Life-threatening dermatologic adverse events in oncology

Photo‐distributed Stevens–Johnson syndrome associated with oral itraconazole

Contact Info

Product

Resources

About